首页 | 本学科首页   官方微博 | 高级检索  
     

两种三联疗法治疗幽门螺杆菌感染成本-效果分析
引用本文:徐珏华,李舡,包晶晶,史峰,张武标. 两种三联疗法治疗幽门螺杆菌感染成本-效果分析[J]. 国外医药(合成药.生化药.制剂分册), 2013, 0(11): 681-683
作者姓名:徐珏华  李舡  包晶晶  史峰  张武标
作者单位:上海电力医院药剂科,上海200050
摘    要:目的分析两种三联疗法治疗幽门螺杆菌(HP)感染成本-效果。方法选取145例HP感染的消化道溃疡患者,随机分为A、B两组,A组服用奥美拉唑、B组服用兰索拉唑,两组均同时服用阿莫西林和甲硝唑,于治疗结束后观察疗效,并进行成本-效果分析。结果两种治疗方案的愈合率(E1)及HP根除率(E2)无差异,成本-效果分析及敏感度分析显示,B组药品成本C/E1、C/E2低于A组,且差异显著(P〈0.01)。结论兰索拉唑联合阿莫西林和甲硝唑治疗HP感染有效、经济、安全。

关 键 词:三联疗法  幽门螺杆菌(HP)  成本-效果分析

Cost-effectiveness analysis of two kinds of triple therapy for Helicobacterpylori
XU Jue-hua,LI Hong,BAO Jing-jing,SHI Feng,ZHANG Wu-biao. Cost-effectiveness analysis of two kinds of triple therapy for Helicobacterpylori[J]. World Pharmacy, 2013, 0(11): 681-683
Authors:XU Jue-hua  LI Hong  BAO Jing-jing  SHI Feng  ZHANG Wu-biao
Affiliation:(Department of Pharmacy, Shanghai Electric Power Hospital, Shanghai 200050, China)
Abstract:Objective To analyze the cost-effectiveness of two kinds of triple therapy for Helicobacter pylori (HP). Methods One hundred and forty-five HP infection patients with peptic ulcer were randomly divided into group A and B. Patients in group A were administrated with omeprazole, amoxicillin and metronidazole. Patients in group B were administrated with lansoprazole, amoxicillin and metronidazole. On the end of the treatment, cost-effectiveness was analyzed. Results The healing rate (El) and HP eradication rate (E2) were no difference in two groups. The cost-effectiveness analysis and sensitivity analysis showed that C/E1 and C/E2 in group B were lower than those in group A (P 〈 0.01). Conclusion Lansoprazole combined with amoxicillin and metronidazole is an efficient, economical and safer treatment for Helicobacter pylori infection.
Keywords:triple therapy  Helicobacterpylori (HP)  cost-effectiveness analysis
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号